RFA
ARIA

Reilly Financial Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Reilly Financial Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$2K – 988
2016
Q4 		$2K Hold
200
– – ﹤0.01% 781
2016
Q3 		$3K Hold
200
– – ﹤0.01% 736
2016
Q2 		$1K Buy
+200
New +$1.5K ﹤0.01% 790
2015
Q4 		– Sell
-200
Closed -$1.31K – 1469
2015
Q3 		$1K Hold
200
– – ﹤0.01% 1241
2015
Q2 		$2K Hold
200
– – ﹤0.01% 1249
2015
Q1 		$2K Sell
200
-100
-33% -$739 ﹤0.01% 1200
2014
Q4 		$2K Buy
+300
New +$1.88K ﹤0.01% 780

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Reilly Financial Advisors's ARIA Position: Q1 2017 in Review

Reilly Financial Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 200 shares — an estimated $2K sold.

Reilly Financial Advisors first reported a position in ARIA in Q4 2014 and held it in 7 quarters. The position peaked at $3K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Reilly Financial Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Reilly Financial Advisors sold 200 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2K.
  • Reilly Financial Advisors first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 7 quarters.
  • Reilly Financial Advisors's Ariad Pharmaceuticals Inc position peaked at $3K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Reilly Financial Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.